Zymeworks Inc.
ZYME · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,294,117 | $945,481 | $895,287 | $1,110,395 |
| - Cash | $64,834,000 | $98,253 | $76,204 | $66,103 |
| + Debt | $18,904,000 | $18,678 | $18,460 | $18,506 |
| Enterprise Value | -$44,635,883 | $865,906 | $837,543 | $1,062,798 |
| Revenue | $27,614 | $48,726 | $27,110 | $31,031 |
| % Growth | -43.3% | 79.7% | -12.6% | – |
| Gross Profit | $27,614 | $48,726 | $27,110 | $31,031 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$15,682 | $2,591 | -$22,323 | -$18,543 |
| % Margin | -56.8% | 5.3% | -82.3% | -59.8% |
| Net Income | -$19,602 | $2,317 | -$22,636 | -$23,506 |
| % Margin | -71% | 4.8% | -83.5% | -75.8% |
| EPS Diluted | -0.26 | 0.03 | -0.3 | -0.31 |
| % Growth | -966.7% | 110% | 3.2% | – |
| Operating Cash Flow | -$31,412 | $12,073 | -$3,407 | -$41,508 |
| Capital Expenditures | -$410 | -$884 | -$338 | -$314 |
| Free Cash Flow | -$31,822 | $11,189 | -$3,745 | -$41,822 |